Toronto - Free Realtime Quote CAD
Satellos Bioscience Inc. (MSCL.TO)
0.6900
+0.0700
+(11.29%)
As of April 23 at 4:00:01 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-24,975
-24,975
-11,585
-5,783
-5,033.7110
Investing Cash Flow
6,338
6,338
-17,538
-3
1,738.1760
Financing Cash Flow
53,485
53,485
50,429
2,775
7,450.7120
End Cash Position
57,659
57,659
22,067
1,924
4,871.2630
Capital Expenditure
-6
-6
-18
-3
-7.2460
Issuance of Capital Stock
42,802
42,802
32,463
2,775
7,078.6760
Issuance of Debt
--
--
2,244
--
186.5730
Repayment of Debt
--
--
-2,622
--
--
Free Cash Flow
-24,981
-24,981
-11,603
-5,786
-5,040.9570
12/31/2021 - 1/7/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EPRX Eupraxia Pharmaceuticals Inc.
4.0000
+4.17%
APLI.TO Appili Therapeutics Inc.
0.0300
0.00%
NGEN.V NervGen Pharma Corp.
2.9500
0.00%
EPRX.TO Eupraxia Pharmaceuticals Inc.
5.28
0.00%
MDNA.TO Medicenna Therapeutics Corp.
1.0400
-0.95%
MOOD.CN Doseology Sciences Inc.
0.1600
0.00%
MESC.CN Lophos Holdings Inc.
0.0100
0.00%
137.SG Aldeyra Therapeutics Inc
2.1230
-0.66%
PHRM.CN PharmaTher Holdings Ltd.
0.1850
0.00%
PHM.VI Pharma Mar, S.A.
81.30
+1.82%